Advertisement

Morphine Injections

[14 July 2015]

Products Affected - Description

Morphine injection, Hospira
15 mg/mL, 1 mL preservative-free Carpuject syringe, 10 count (NDC 00409-1894-01)
25 mg/mL, 4 mL ADD-Vantage vial, 50 count (NDC 00409-6177-14)
25 mg/mL, 10 mL ADD-Vantage vial, 50 count (NDC 00409-6179-14)
 
Morphine injection, West-Ward
8 mg/mL, 1 mL vial, 25 count (NDC 00641-6075-25)
 
Duramorph (preservative-free), West-Ward
1 mg/mL, 10 mL ampules, 10 count (NDC 00641-6019-10)

Reason for the Shortage

  • Fresenius Kabi states the shortage is due to a change in manufacturing sites and cannot estimate when Astramorph will return.
  • Hospira states the shortage is due to manufacturing delays.
  • West-Ward states the shortage was due to increased demand for product.

Available Products

Morphine Injection, BD Rx
2 mg/mL, 1 mL preservative-free syringe, 24 count (NDC 76045-0004-10)
4 mg/mL, 1 mL preservative-free syringe, 24 count (NDC 76045-0005-10)
5 mg/mL, 1 mL preservative-free syringe, 24 count (NDC 76045-0006-10)
8 mg/mL, 1 mL preservative-free syringe, 24 count (NDC 76045-0007-10)
10 mg/mL, 1 mL preservative-free syringe, 24 count (NDC 76045-0008-10)
 
Morphine Injection, Hospira
0.5 mg/mL 10 mL, preservative-free vial, 25 count (NDC 00409-3814-12)
1 mg/mL 10 mL preservative-free vial, 25 count (NDC 00409-3815-12)
2 mg/mL, 1 mL preservative-free Carpuject syringe, 10 count (NDC 00409-1890-01)
2 mg/mL, 1 mL preservative-free iSecure syringe, 10 count (NDC 00409-1890-11)
4 mg/mL, 1 mL preservative-free Carpuject syringe, 10 count (NDC 00409-1891-01)
4 mg/mL, 1 mL preservative-free iSecure syringe, 10 count (NDC 00409-1891-11)
8 mg/mL, 1 mL preservative-free Carpuject syringe, 10 count (NDC 00409-1892-01)
10 mg/mL, 1 mL preservative-free Carpuject syringe, 10 count (NDC 00409-1893-01)
1 mg/mL, 30 mL PCA vial, 25 count (NDC 00409-2029-02)
5 mg/mL, 30 mL PCA vial, 25 count (NDC 00409-6028-04)
25 mg/mL, 1 mL preservative-free vial, 50 count (NDC 00409-1135-02)
50 mg/mL, 20 mL vial, 50 count (NDC 00409-1134-03)
50 mg/mL, 50 mL vial, 50 count (NDC 00409-1134-05)
 
Morphine injection, West-Ward
5 mg/mL, 1 mL vial, 25 count (NDC 00641-6073-25)
10 mg/mL, 1 mL vial, 25 count (NDC 00641-6070-25)
10 mg/mL, 10 mL vial, single count (NDC 00641-6068-01)
15 mg/mL, 1 mL vial, 25 count (NDC 00641-6071-25)
15 mg/mL, 20 mL vial, single count (NDC 00641-6072-01)
 
Duramorph (preservative-free), West-Ward
0.5 mg/mL, 10 mL ampules, 10 count (NDC 00641-6020-10)
 
Infumorph (preservative-free), West-Ward
10 mg/mL, 20 mL ampule, single count (NDC 00641-6039-01)
25 mg/mL, 20 mL ampule, single count (NDC 00641-6040-01)

Estimated Resupply Dates

  • Fresenius Kabi has all preservative-free Astramorph presentations on long-term back order and the company cannot estimate a release date.
  • Hospira has morphine 25 mg/mL 4 mL and 10 mL ADD-Vantage vials on back order and the company cannot estimate a release date. The 15 mg/mL 1 mL Carpuject syringes are on back order and the company cannot estimate a release date.
  • West-Ward has Duramorph 1 mg/mL 10 mL ampules on allocation. Infumorph 25 mg/mL 20 mL ampules are available with regular dating and with expiration of November 2015. Morphine 8 mg/mL 1 mL vials are available only with an expiration date of June 2016.

Related Shortages

Updated

July 1 and 14, May 11, March 31, February 20, 2015; December 1 and 22, November 10 and 14, October 2, 17, and 31, September 23, August 29, July 30, June 12, May 12 and 19, April 16 and 23, March 5 and 31, February 14, 2014; December 10, November 1, October 11, September 3, August 14, July 12, June 4, April 25, March 21, February 6, January 23, 2013; December 12, November 30, October 24, September 26, August 31, June 15, May 25, April 20, March 21, February 23, January 24, 2012; December 22, November 21, October 19, September 29, August 19, July 14 and 28, June 23, May 5, March 24, February 15, January 6, 2011; December 2, November 17, October 28, September 28, August 30, July 16, June 24, May 19, 2010; December 2, November 11, October 21, September 16, July 16, June 23, 2009, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT. 

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement